125 related articles for article (PubMed ID: 34097440)
1. Machine Learning Methods to Identify Missed Cases of Bladder Cancer in Population-Based Registries.
Noone AM; Lam CJK; Smith AB; Nielsen ME; Boyd E; Mariotto AB; Banerjee M
JCO Clin Cancer Inform; 2021 Jun; 5():641-653. PubMed ID: 34097440
[TBL] [Abstract][Full Text] [Related]
2. Using the SEER-Medicare Data to Assess Incident Chronic Myeloid Leukemia and Bladder Cancer Cases Missed by Cancer Registries.
Lam CJK; Warren JL; Nielsen M; Smith A; Boyd E; Barrett MJ; Mariotto AB
J Natl Cancer Inst Monogr; 2020 May; 2020(55):31-38. PubMed ID: 32412074
[TBL] [Abstract][Full Text] [Related]
3. An approach to identifying incident breast cancer cases using Medicare claims data.
Freeman JL; Zhang D; Freeman DH; Goodwin JS
J Clin Epidemiol; 2000 Jun; 53(6):605-14. PubMed ID: 10880779
[TBL] [Abstract][Full Text] [Related]
4. Development of a Machine Learning Model to Identify Colorectal Cancer Stage in Medicare Claims.
Finn CB; Sharpe JE; Tong JK; Kaufman EJ; Wachtel H; Aarons CB; Weissman GE; Kelz RR
JCO Clin Cancer Inform; 2023 May; 7():e2300003. PubMed ID: 37257142
[TBL] [Abstract][Full Text] [Related]
5. Health Related Quality of Life Following Radical Cystectomy: Comparative Analysis from the Medicare Health Outcomes Survey.
Winters BR; Wright JL; Holt SK; Dash A; Gore JL; Schade GR
J Urol; 2018 Mar; 199(3):669-675. PubMed ID: 28882404
[TBL] [Abstract][Full Text] [Related]
6. Classifying Stage IV Lung Cancer From Health Care Claims: A Comparison of Multiple Analytic Approaches.
Brooks GA; Bergquist SL; Landrum MB; Rose S; Keating NL
JCO Clin Cancer Inform; 2019 May; 3():1-19. PubMed ID: 31070985
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of coding algorithms to identify patients with incident lung cancer in United States healthcare claims data.
Beyrer J; Nelson DR; Sheffield KM; Huang YJ; Ellington T; Hincapie AL
Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1465-1479. PubMed ID: 33012044
[TBL] [Abstract][Full Text] [Related]
8. Cancer registry problems in classifying invasive bladder cancer.
Lynch CF; Platz CE; Jones MP; Gazzaniga JM
J Natl Cancer Inst; 1991 Mar; 83(6):429-33. PubMed ID: 1999849
[TBL] [Abstract][Full Text] [Related]
9. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
[TBL] [Abstract][Full Text] [Related]
10. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries.
Walker GV; Giordano SH; Williams M; Jiang J; Niu J; MacKinnon J; Anderson P; Wohler B; Sinclair AH; Boscoe FP; Schymura MJ; Buchholz TA; Smith BD
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):686-93. PubMed ID: 23773392
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Ray-Zack MD; Hudgins HK; Jazzar U; Tyler DS; Freedland SJ; Swanson TA; Baillargeon JG; Hu JC; Kaul S; Kamat AM; Gore JL; Mehta HB
JAMA Surg; 2019 Aug; 154(8):e191629. PubMed ID: 31166593
[TBL] [Abstract][Full Text] [Related]
12. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
Brown ML; Riley GF; Potosky AL; Etzioni RD
Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
[TBL] [Abstract][Full Text] [Related]
13. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
[TBL] [Abstract][Full Text] [Related]
14. Ability of Medicare claims data and cancer registries to identify cancer cases and treatment.
McClish DK; Penberthy L; Whittemore M; Newschaffer C; Woolard D; Desch CE; Retchin S
Am J Epidemiol; 1997 Feb; 145(3):227-33. PubMed ID: 9012595
[TBL] [Abstract][Full Text] [Related]
15. Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly.
Engels EA; Pfeiffer RM; Ricker W; Wheeler W; Parsons R; Warren JL
Am J Epidemiol; 2011 Oct; 174(7):860-70. PubMed ID: 21821540
[TBL] [Abstract][Full Text] [Related]
16. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
17. Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
Richards KA; Ham S; Cohn JA; Steinberg GD
Int J Urol; 2016 Jan; 23(1):42-7. PubMed ID: 26443388
[TBL] [Abstract][Full Text] [Related]
18. Cancer Incidence in Older Adults in the United States: Characteristics, Specificity, and Completeness of the Data.
Weir HK; Sherman R; Yu M; Gershman S; Hofer BM; Wu M; Green D
J Registry Manag; 2020; 47(3):150-160. PubMed ID: 33584972
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of population-based bladder cancer registries: How criteria heterogeneity affects the comparison of incidences.
Caballero JM; Gili JM; Pereira JC; Gomáriz A; Castillo C; Martín-Baranera M
Cancer Med; 2023 Mar; 12(6):7540-7551. PubMed ID: 36530046
[TBL] [Abstract][Full Text] [Related]
20. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.
Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS
Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
